Avrobio Inc reported $17.13M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Akebia Therapeutics AKBA:US $ 253.91M 2.58M
Alnylam Pharmaceuticals ALNY:US $ 605.96M 89.75M
Applied Genetic Technologies AGTC:US $ 25.81M 1.7M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Epizyme EPZM:US $ 38.97M 6.23M
Gilead Sciences GILD:US $ 8558M 3052M
Intercept Pharmaceuticals ICPT:US $ 151.04M 15.78M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Karyopharm Therapeutics KPTI:US $ 66.34M 7.38M
Macrogenics MGNX:US $ 67.1M 7.48M
Pfizer PFE:US $ 39268M 3403M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Sarepta Therapeutics SRPT:US $ 454.96M 2.23M
Takeda 4502:JP Y 2145730M 336476M